Skip to main content

Table 1 The scores for NEO PI-R and STAI according to the genotypes of each polymorphism

From: No association of DRD2, DRD3, and tyrosine hydroxylase gene polymorphisms with personality traits in the Japanese population

 

NEO PI-R factors

STAI

Genotype

N (%)

Neuroticism

Extraversion

Openness

Agreeableness

Conscientiousness

N (%)

State Anxiety

Trait Anxiety

DRD2 gene

   -241A/G polymorphism

   A/A

197 (77.9)

100.4 ± 20.7

97.3 ± 15.1

110.5 ± 14.3

112.9 ± 12.7

100.6 ± 16.6

184 (79.3)

42.3 ± 9.7

44.6 ± 10.7

   A/G

53 (20.9)

94.6 ± 18.6

99.4 ± 12.3

108.7 ± 12.7

115.2 ± 14.3

102.6 ± 18.0

45 (19.4)

38.8 ± 7.5

39.8 ± 8.9

   G/G

3 (1.2)

110.0 ± 17.1

98.0 ± 15.1

112.7 ± 17.7

120.3 ± 3.1

105.3 ± 12.7

3 (1.3)

42.7 ± 7.5

45.3 ± 7.6

   -141C Ins/Del polymorphism

   Ins/Ins

159 (62.6)

98.0 ± 20.0

97.3 ± 14.2

109.3 ± 14.2

113.7 ± 12.4

102.0 ± 16.8

146 (62.7)

42.7 ± 9.6*

43.8 ± 10.5

   Ins/Del

83 (32.7)

101.4 ± 19.1

99.2 ± 15.0

111.5 ± 13.8

112.3 ± 14.5

99.4 ± 17.1

76 (32.6)

39.8 ± 8.3

43.3 ± 10.3

   Del/Del

12 (4.7)

104.4 ± 25.1

92.7 ± 16.0

111.8 ± 10.5

119.9 ± 7.9

99.2 ± 15.7

11 (4.7)

39.3 ± 11.8

45.7 ± 11.8

   Ser311Cys polymorphism

   Ser/Ser

240 (94.5)

99.6 ± 20.2

97.9 ± 14.6

110.5 ± 13.8

113.4 ± 13.1

100.7 ± 16.9

222 (94.9)

41.8 ± 9.4

44.0 ± 10.5*

   Ser/Cys

14 (5.5)

90.1 ± 11.8

96.3 ± 12.9

104.4 ± 14.7

117.7 ± 10.5

107.0 ± 9.9

12 (5.1)

37.4 ± 7.9

37.1 ± 5.6

Ser9Gly polymorphism of the DRD3 gene

   Ser/Ser

125 (52.5)

99.8 ± 19.8

98.3 ± 15.3

110.4 ± 14.2

113.3 ± 13.3

101.5 ± 17.2

116 (53.2)

41.3 ± 8.4

43.4 ± 9.4

   Ser/Gly

92 (38.7)

97.3 ± 19.8

97.7 ± 13.1

110.8 ± 13.8

114.1 ± 12.4

101.9 ± 17.1

82 (37.6)

41.0 ± 10.1

42.6 ± 11.2

   Gly/Gly

21 (8.8)

103.3 ± 19.4

95.4 ± 15.4

106.9 ± 14.0

112.0 ± 15.0

93.5 ± 13.7

20 (9.2)

44.7 ± 9.9

48.0 ± 12.5

TH gene

   Val81Met polymorphism

   Val/Val

24 (12.4)

96.5 ± 22.6

101.0 ± 17.0

108.2 ± 16.5

110.8 ± 8.8

98.7 ± 17.0

22 (12.4)

42.0 ± 8.7

44.2 ± 10.4

   Val/Met

80 (41.2)

100.2 ± 17.5

96.1 ± 14.4

108.4 ± 15.2

115.2 ± 12.3

100.7 ± 16.7

74 (41.8)

41.3 ± 7.5

45.1 ± 10.0

   Met/Met

90 (46.4)

100.1 ± 20.9

98.7 ± 13.6

111.0 ± 12.4

112.3 ± 12.8

98.7 ± 17.3

81 (45.8)

40.8 ± 10.1

42.3 ± 10.5

   Pst I site polymorphism

   AA

43 (18.4)

96.2 ± 20.8

100.6 ± 14.4

112.5 ± 11.6

112.2 ± 12.1

99.9 ± 17.1

42 (19.0)

40.6 ± 9.8

41.6 ± 11.1*

   AB

130 (55.5)

100.8 ± 19.8

96.1 ± 14.5

109.3 ± 14.1

113.9 ± 14.0

100.6 ± 16.4

122 (55.2)

41.8 ± 9.4

44.9 ± 10.3

   BB

61 (26.1)

96.9 ± 18.7

101.0 ± 14.2

109.6 ± 14.5

114.1 ± 9.8

101.4 ± 17.4

57 (25.8)

41.3 ± 8.4

42.2 ± 10.0

  1. Scores presented as mean ± standard deviation.
  2. * p < 0.05, ANCOVA, sex and age were included as covariates.